Paragraph 34 — part 2
Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness
A10-0123/2025 – Hildegard Bentele – § 34/2
Adopted
- For
- 566
- Against
- 60
- Abstained
- 23
roll-call vote at 13:15 · 87% of votes cast in favour
Roll call requested by Members · split vote by Members
The part voted on: ‘underlines that the sector is characterised by high levels of risk and that reducing the cost of investment failure in the EU is necessary for attracting large-scale capital investment; calls for dedicated support to ensure that biotechnology and biomanufacturing SMEs, start-ups and scale-ups can access sufficient funding and compete globally; stresses that cross-border investment barriers must be reduced to facilitate investment in biotechnology and biomanufacturing scale-ups;’
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 12 | 25 | 1 | 38 | Divided |
| Greens | 47 | 0 | 4 | 51 | For |
| S&D | 117 | 0 | 0 | 117 | For |
| Renew | 68 | 0 | 0 | 68 | For |
| EPP | 173 | 2 | 0 | 175 | For |
| ECR | 64 | 2 | 6 | 72 | For |
| Patriots | 73 | 6 | 0 | 79 | For |
| ESN | 2 | 18 | 5 | 25 | Against |
| No group | 10 | 7 | 7 | 24 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
25 MEPs of 649 Clear filters
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.